NEW YORK, NY--(MARKET WIRE)--Jul 18, 2007 -- The Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Dementias (AFTD) are pleased to announce a new grant award program entitled Frontotemporal Dementia Drug Discovery. This three-year collaborative program will provide a total of $900,000 to support academic and biotechnology industry scientists worldwide conducting drug discovery research on innovative therapies for frontotemporal dementia (FTD).
